Antibodies to retroviruses in recent onset psychosis and multi-episode schizophrenia

Schizophrenia Research

Volumn 138, Issue 2-3, 2012, Pages 198-205

  Dickerson, Faith ^a   Lillehoj, Erik ^b   Stallings, Cassie ^a   Wiley, Melanie ^b   Origoni, Andrea ^a   Vaughan, Crystal ^a   Khushalani, Sunil ^a   Sabunciyan, Sarven ^c   Yolken, Robert ^c  

^a Stanley Research Program at Sheppard Pratt   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibody; Immunity; Psychosis; Retrovirus; Schizophrenia

Indexed keywords

GAG PROTEIN; GENOMIC DNA; IMMUNOGLOBULIN G ANTIBODY; POL PROTEIN; VIRUS DNA; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DNA SEQUENCE; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FELINE IMMUNODEFICIENCY VIRUS; FEMALE; HUMAN; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; MASON PFIZER MONKEY VIRUS; MOLECULAR PATHOLOGY; MURINE LEUKEMIA VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; DNA, VIRAL; FEMALE; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; LEUKEMIA VIRUS, MURINE; MALE; MASON-PFIZER MONKEY VIRUS; MIDDLE AGED; PSYCHOTIC DISORDERS; REAL-TIME POLYMERASE CHAIN REACTION; RETROVIRIDAE INFECTIONS; SCHIZOPHRENIA;

EID: 84862125878     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.03.037     Document Type: Article

References (38)

1. Bannert N., Kurth R. Retroelements and the human genome: new perspectives on an old relation. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(Suppl. 2):14572-14579.
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
3. Bromet E.J., Kotov R., Fochtmann L.J., Carlson G.A., Tanenberg-Karant M., Ruggero C., Chang S.W. Diagnostic shifts during the decade following first admission for psychosis. Am. J. Psychiatry 2011, 168(11):1186-1194.
4. Carlini F., Ridolfi B., Molinari A., Parisi C., Bozzuto G., Toccacieli L., Formisano G., De Orsi D., Paradisi S., Grober O.M., Ravo M., Weisz A., Arcieri R., Vella S., Gaudi S. The reverse transcription inhibitor abacavir shows anticancer activity in prostate cancer cell lines. PLoS One 2010, 5(12):e14221.
5. Christensen T. HERVs in neuropathogenesis. J. Neuroimmune Pharmacol. 2010, 5(3):326-335.
6. Cowan E.P., Nemo G.J., Williams A.E., Alexander R.K., Vallejo A., Hewlett I.K., Lal R.B., Dezzutti C.S., Gallahan D., George K., Pancake B.A., Zucker-Franklin D., McCurdy P.R., Tabor E. Absence of human T-lymphotropic virus type I tax sequences in a population of normal blood donors in the Baltimore, MD/Washington, DC, area: results from a multicenter study. Transfusion 1999, 39(8):904-909.
7. Dickerson F.B., Boronow J.J., Stallings C., Origoni A.E., Ruslanova I., Yolken R.H. Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Arch. Gen. Psychiatry 2003, 60(5):466-472.
8. Dickerson F.B., Stallings C., Origoni A., Boronow J.J., Sullens A., Yolken R. Predictors of occupational status six months after hospitalization in persons with a recent onset of psychosis. Psychiatry Res. 2008, 160(3):278-284.
9. Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Leister F., Yang S., Krivogorsky B., Alaedini A., Yolken R. Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biol. Psychiatry 2010, 68(1):100-104.
10. Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Alaedini A., Yolken R. Markers of gluten sensitivity and celiac disease in bipolar disorder. Bipolar Disord. 2011, 13(1):52-58.
11. Diem O., Schäffner M., Seifarth W., Leib-Mösch C. Influence of antipsychotic drugs on human endogenous retrovirus (HERV) transcription in brain cells. PLoS One 2012, 7(1):e30054. 10.1371/journal.pone.0030054.
12. Feenstra A., Kirch D.G., Bracha H.S., Wyatt R.J. Lack of evidence for a role of T-cell-associated retroviruses as an etiology of schizophrenia. Biol. Psychiatry 1989, 25(4):421-430.
13. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition 1998, (SCID-I/P), Biometrics Research, New York State Psychiatric Institute, New York.
14. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders-Non-patient Edition 1998, (SCID-I/NP), Biometrics Research, New York State Psychiatric Institute, New York.
15. Frank O., Jones-Brando L., Leib-Mosch C., Yolken R., Seifarth W. Altered transcriptional activity of human endogenous retroviruses in neuroepithelial cells after infection with Toxoplasma gondii. J. Infect. Dis. 2006, 194(10):1447-1449.
16. Retroviruses 1997, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. S.H. Hughes, H.E. Varmus (Eds.).
17. Jones-Brando L.V., Buthod J.L., Holland L.E., Yolken R.H., Torrey E.F. Metabolites of the antipsychotic agent clozapine inhibit the replication of human immunodeficiency virus type 1. Schizophr. Res. 1997, 25(1):63-70.
18. Karlsson H., Bachmann S., Schröder J., McArthur J., Torrey E.F., Yolken R.H. Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(8):4634-4639.
19. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13(2):261-276.
20. Knight J.G., Menkes D.B., Highton J., Adams D.D. Rationale for a trial of immunosuppressive therapy in acute schizophrenia. Mol. Psychiatry 2007, 12(5):424-431.
21. Kubo K., Fujiyoshi T., Yokoyama M.M., Kamei K., Richt J.A., Kitze B., Herzog S., Takigawa M., Sonoda S. Lack of association of Borna disease virus and human T-cell leukemia virus type 1 infections with psychiatric disorders among Japanese patients. Clin. Diagn. Lab. Immunol. 1997, 4(2):189-194.
22. Lerche N.W., Switzer W.M., Yee J.L., Shanmugam V., Rosenthal A.N., Chapman L.E., Folks T.M., Heneine W. Evidence of infection with simian type D retrovirus in persons occupationally exposed to nonhuman primates. J. Virol. 2001, 75(4):1783-1789.
23. Lillehoj E.P., Ford G.M., Bachmann S., Schröder J., Torrey E.F., Yolken R.H. Serum antibodies reactive with non-human primate retroviruses identified in acute onset schizophrenia. J. Neurovirol. 2000, 6(6):492-497.
24. Nellåker C., Yao Y., Jones-Brando L., Mallet F., Yolken R.H., Karlsson H. Transactivation of elements in the human endogenous retrovirus W family by viral infection. Retrovirology 2006, 3:44.
25. Patterson P.H. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav. Brain Res. 2009, 204(2):313-321.
26. Perron H., Mekaoui L., Bernard C., Veas F., Stefas I., Leboyer M. Endogenous retrovirus type W GAG and envelope protein antigenemia in serum of schizophrenic patients. Biol. Psychiatry 2008, 64(12):1019-1023.
27. Pop M., Salzberg S.L., Shumway M. Genome sequence assembly: algorithms and issues. Computer 2002, 35(7):47-54.
28. Severance E.G., Dickerson F.B., Viscidi R.P., Bossis I., Stallings C.R., Origoni A.E., Sullens A., Yolken R.H. Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms. Schizophr. Bull. 2011, 37(1):101-107.
29. Shi M., Wang X., Okamoto M., Takao S., Baba M. Inhibition of porcine endogenous retrovirus (PERV) replication by HIV-1 gene expression inhibitors. Antiviral Res. 2009, 83(2):201-204.
30. Tandon R., Sengupta D., Ndhlovu L.C., Vieira R.G., Jones R.B., York V.A., Vieira V.A., Sharp E.R., Wiznia A.A., Ostrowski M.A., Rosenberg M.G., Nixon D.F. Identification of human endogenous retrovirus (HERV)-specific T cell responses in vertically HIV-1-infected subjects. J. Virol. 2011, 85(21):11526-11531.
31. Tiwari A.K., Zai C.C., Müller D.J., Kennedy J.L. Genetics in schizophrenia: where are we and what next?. Dialogues Clin. Neurosci. 2010, 12(3):289-303.
32. Torrey E.F., Yolken R.H. The schizophrenia-rheumatoid arthritis connection: infectious, immune, or both?. Brain Behav. Immun. 2001, 15:401-410.
33. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 1979, 76(9):4350-4354.
34. Tyekucheva S., Yolken R.H., McCombie W.R., Parla J., Kramer M., Wheelan S.J., Sabunciyan S. Establishing the baseline level of repetitive element expression in the human cortex. BMC Genomics 2011, 12(1):495.
35. Weis S., Llenos I.C., Sabunciyan S., Dulay J.R., Isler L., Yolken R., Perron H. Reduced expression of human endogenous retrovirus (HERV)-W GAG protein in the cingulate gyrus and hippocampus in schizophrenia, bipolar disorder, and depression. J. Neural Transm. 2007, 114(5):645-655.
36. Xu A.G., He L., Li Z., Xu Y., Li M., Fu X., Yan Z., Yuan Y., Menzel C., Li N., Somel M., Hu H., Chen W., Pääbo S., Khaitovich P. Intergenic and repeat transcription in human, chimpanzee and macaque brains measured by RNA-Seq. PLoS Comput. Biol. 2010, 6:e1000843.
37. Yao Y., Schröder J., Nellåker C., Bottmer C., Bachmann S., Yolken R.H., Karlsson H. Elevated levels of human endogenous retrovirus-W transcripts in blood cells from patients with first episode schizophrenia. Genes Brain Behav. 2008, 7(1):103-112.
38. Yolken R.H., Karlsson H., Yee F., Johnston-Wilson N.L., Torrey E.F. Endogenous retroviruses and schizophrenia. Brain Res. Brain Res. Rev. 2000, 31(2-3):193-199.